BioNTech AG to Present at Cantor Fitzgerald Healthcare Conference

Mainz, Germany, September 19, 2017 – BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at the Cantor Fitzgerald Healthcare Conference that is being held in New York, NY from September 25-27, 2017. The presentation is scheduled for Tuesday, September 26 at 2:50 PM Eastern Daylight Time.

Mr. Marett will provide an overview of the Company´s strategy and its most recent substantial progress, including an update of its clinical pipeline, an overview of its strategic collaborations and a summary of its most recent Nature publication related to its neo-epitope based individualized mRNA cancer immunotherapeutic.

Download PDF version of the announcement.